Abstract
Diabetes is the leading cause of chronic kidney disease (CKD), a condition associated with significant morbidity and mortality. As these patients have a high risk of developing cardiovascular disease and end-stage kidney disease, there is a need for early detection and early initiation of appropriate therapeutic interventions that slow disease progression and prevent adverse outcomes. Due to the complex nature of diabetes and CKD management, a holistic, patient-centered, collaborative care approach delivered by a coordinated multidisciplinary team (ideally including a clinical pharmacist as part of a comprehensive medication management program) is needed. In this review, we discuss the barriers to effective care, the current multidisciplinary approach used for CKD prevention and treatment, and the potential ways that the multidisciplinary management of CKD associated with type 2 diabetes mellitus can be refined to improve patient outcomes.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1111-1136 |
| Number of pages | 26 |
| Journal | Diabetes Therapy |
| Volume | 14 |
| Issue number | 7 |
| DOIs | |
| State | Published - Jul 2023 |
Bibliographical note
Funding Information:Medical writing support and the journal’s Rapid Service Fee was funded by Bayer Corporation. The authors did not receive any honoraria for this review.
Publisher Copyright:
© 2023, The Author(s).
Keywords
- Care optimization
- Chronic kidney disease
- Multidisciplinary care
- Multidisciplinary team
- Prevention
- Type 2 diabetes mellitus
PubMed: MeSH publication types
- Journal Article
- Review
